Dr. Andrew Muir, Duke University hepatologist, offers an update of the latest Hepatitis C research being presented at DDW 2013 in Orlando, Fla., and what benefits may accrue to patients in the coming years.
With many new drugs coming forward, Muir said he provides his patients with time frames on the availability of these medications, including the much-anticipated interferon-free regimens. By understanding the regimens, a patient’s liver disease and what’s right for them, he says individualizing plans allows clinicians to better guide patients on timelines and expectations.
With many new drugs coming forward, Muir said he provides his patients with time frames on the availability of these medications, including the much-anticipated interferon-free regimens. By understanding the regimens, a patient’s liver disease and what’s right for them, he says individualizing plans allows clinicians to better guide patients on timelines and expectations.
http://video.healio.com/video/Andrew-Muir-MD-DDW-2013
No comments:
Post a Comment